HEE-JIN JANG to Carcinoma, Hepatocellular
This is a "connection" page, showing publications HEE-JIN JANG has written about Carcinoma, Hepatocellular.
Connection Strength
0.314
-
Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes. Hepatology. 2022 12; 76(6):1634-1648.
Score: 0.097
-
Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials. Cancer Commun (Lond). 2022 02; 42(2):179-183.
Score: 0.094
-
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology. 2016 Jan; 63(1):159-72.
Score: 0.062
-
Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma. Clin Cancer Res. 2016 Mar 01; 22(5):1256-64.
Score: 0.061